The clinical outcomes of second-line chemotherapy in patients with advanced pancreatic cancer: a retrospective analysis.
Hyun Yeb JungEun Mi Lee
Published in: Yeungnam University journal of medicine (2021)
The survival outcome of second-line chemotherapy for advanced pancreatic cancer remains poor. However, PS, disease extent (locally advanced or metastatic), and CEA level may help determine patients who could benefit from second-line treatment.